Distinct but complementary contributions of PPAR isotypes to energy homeostasis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28368286.
- Also identified by DOI 10.1172/JCI88894 and PMC identifier 5373878.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Peroxisome proliferator-activated receptors (PPARs) regulate energy metabolism and hence are therapeutic targets in metabolic diseases such as type 2 diabetes and non-alcoholic fatty liver disease. While they share anti-inflammatory activities, the PPAR isotypes distinguish themselves by differential actions on lipid and glucose homeostasis. In this Review we discuss the complementary and distinct metabolic effects of the PPAR isotypes together with the underlying cellular and molecular mechanisms, as well as the synthetic PPAR ligands that are used in the clinic or under development. We highlight the potential of new PPAR ligands with improved efficacy and safety profiles in the treatment of complex metabolic disorders.
Medical subject headings
- Diabetes Mellitus, Type 2
- Energy Metabolism
- Non-alcoholic Fatty Liver Disease
- Peroxisome Proliferator-Activated Receptors